| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Apr―24 |
The effects of G1899 Korean red ginseng extract powder on long COVID for acute COVID19 infection: A randomized, double-blind, placebo-controlled trial |
In-Ho Seo, Byoungjin Park, Heejung Kim, Seok-Jae Heo, Dong-Hyuk Jung |
| 2 |
[GO] |
2024―Nov―23 |
Korean Red Ginseng relieves the inflammation and oxidative stress induced by pseudo-typed SARS-CoV-2 |
Hyeon Jin Kim, Yena Oh, Sohee Moon, Jieun Oh, Ji Hye Kim, Seung Ho Lee, et al. (+7) Sun Hee Hyun, Ji Hye Park, Hun-kun Ko, Jaehyeon Hwang, Han Gyung Kim, Dae Hyuk Kweon, Jae Youl Cho |
| 3 |
[GO] |
2023―Nov―02 |
Ginseng and ginsenosides on cardiovascular and pulmonary diseases; Pharmacological potentials for the coronavirus (COVID-19) |
Ajay Vijayakumar, Jong-Hoon Kim |
| 4 |
[GO] |
2023―Apr―08 |
The potential of Panax notoginseng against COVID-19 infection |
Yeye Hu, Ziliang He, Wei Zhang, Zhiqiang Niu, Yanting Wang, Ji Zhang, et al. (+3) Ting Shen, Hong Cheng, Weicheng Hu |
| 5 |
[GO] |
2022―Dez―29 |
COVID-19 infection and ginseng: Predictive influenza virus strains and non-predictive COVID-19 vaccine strains |
Dong-Kwon Rhee |
| 6 |
[GO] |
2022―Okt―12 |
Ginsenoside Rg3, a promising agent for NSCLC patients in the pandemic: A large-scale data mining and systemic biological analysis |
Zhenjie Zhuang, Qianying Chen, Xiaoying Zhong, Huiqi Chen, Runjia Yu, Ying Tang |
| 7 |
[GO] |
2022―Okt―08 |
The relationship of skin disorders, COVID-19, and the therapeutic potential of ginseng: a review |
Seoyeon Yang, Su Bin Han, Soohyun Kang, Junghyun Lee, Dongseon Kim, Anastasiia Kozlova, et al. (+3) Minkyung Song, See-Hyoung Park, Jongsung Lee |
| 8 |
[GO] |
2022―Okt―05 |
Antiviral effects of Korean Red ginseng on human coronavirus OC43 |
Chi Hwan Jeong, Jisu Kim, Bo Kyeong Kim, Kang Bin Dan, Hyeyoung Min |
| 9 |
[GO] |
2022―Okt―04 |
Panax ginseng as a potential therapeutic for neurological disorders associated with COVID-19; Toward targeting inflammasome |
Seo Won Shin, Ik Hun Cho |
| 10 |
[GO] |
2022―Sep―17 |
In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism |
Yixian Quah, Yuan Yee Lee, Seung-Jin Lee, Sung Dae Kim, Man Hee Rhee, Seung-Chun Park |
| 11 |
[GO] |
2022―Aug―11 |
Protective role of Ginseng in endomertriosis during covid-19 |
JiHyeon Song, YoungJoo Lee |
| 12 |
[GO] |
2022―Jul―15 |
Production and characterization of lentivirus vector-based SARS-CoV-2 pseudoviruses with dual reporters: Evaluation of anti-SARS-CoV-2 viral effect of Korean red ginseng |
Jeonghui Moon, Younghun Jung, Seokoh Moon, Jaehyeon Hwang, Soomin Kim, Mi Soo Kim, et al. (+5) Jeong Hyeon Yoon, Kyeongwon Kim, Youngseo Park, Jae Youl Cho, Dae-Hyuk Kweon |
| 13 |
[GO] |
2022―Apr―05 |
Potential benefits of ginseng against COVID-19 by targeting inflammasomes |
Young-Su Yi |
| 14 |
[GO] |
2022―Feb―25 |
Can Panax ginseng help control cytokine storm in COVID-19? |
Jong Hee Choi, Young Hyun Lee, Tae Woo Kwon, Seong-Gyu Ko, Seung-Yeol Nah, Ik-Hyun Cho |
| 15 |
[GO] |
2022―Feb―17 |
Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic |
Eui-Man Jung, Geun-Shik Lee |
| 16 |
[GO] |
2022―Jan―22 |
Ginseng, a promising choice for SARS-COV-2: A mini review |
Zubair Ahmed Ratan, Fazla Rabbi Mashrur, Nusrat Jahan Runa, Ki Woong Kwon, Hassan Hosseinzadeh, Jae Youl Cho |
| 17 |
[GO] |
2022―Jan―19 |
Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: A systematic review |
Mohammad Amjad Hossain, Jong-Hoon Kim |
| 18 |
[GO] |
2022―Jan―19 |
COVID-19 and Panax ginseng: Targeting platelet aggregation, thrombosis and the coagulation pathway |
Yuan Yee Lee, Yixian Quah, Jung-Hae Shin, Hyuk-Woo Kwon, Dong-Ha Lee, Jee Eun Han, et al. (+5) Jin-Kyu Park, Sung Dae Kim, Dongmi Kwak, Seung-Chun Park, Man Hee Rhee |
| 19 |
[GO] |
2021―Feb―19 |
Corona-Cov-2 (COVID-19) and ginseng: Comparison of possible use in COVID-19 and influenza |
Won Sik Lee, Dong-Kwon Rhee |
